{Reference Type}: Case Reports
{Title}: HDR syndrome, detected in the neonatal period by newborn hearing screening.
{Author}: Takai S;Adachi M;Takahashi H;Shirakura M;Honkura Y;Yamauchi D;Katori Y;
{Journal}: Auris Nasus Larynx
{Volume}: 51
{Issue}: 2
{Year}: 2024 Apr 27
{Factor}: 2.119
{DOI}: 10.1016/j.anl.2023.08.007
{Abstract}: Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is an autosomal dominant disorder. Because HDR syndrome is caused by haploinsufficiency in GATA3, it exhibits variation in the onset and progression of hearing loss. In previous reports, the automated auditory brainstem response (AABR) was considered insufficient to detect sensorineural hearing loss caused by HDR syndrome. We report a case of HDR syndrome whose congenital hearing loss was detected by newborn hearing screening (NHS) using AABR. In this case, HDR syndrome was suspected due to hearing loss, hypocalcemia, and her family history. Genetic testing confirmed the diagnosis of HDR syndrome at 5 months of age. Because the phenotype of hearing loss due to HDR syndrome is variable and includes progressive hearing loss, these cases may not be detected by the HNS. However, most of the previous reports were published before the NHS became common and given the frequency of hearing loss complications in HDR syndrome. We consider that there is a reasonable number of HDR syndrome cases with abnormalities on the NHS. We believe that the NHS may also be useful for early detection of hearing loss due to HDR syndrome.